Showing results (411-420 of 578) with videos related to
Sort By:
Pageof 58
Journal of Vascular and Interventional Neurology|August 25, 2015
Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen ActivatorGrant C Sorkin, Travis M Dumont, Maxim Mokin, et al.The Journal of Biological Chemistry|October 7, 2008
Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophagesParisa Kalantari, Vivek Narayan, Sathish K Natarajan, et al.Neurosurgery|October 17, 2009
Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onsetMarlon S Mathews, Jitendra Sharma, Kenneth V Snyder, et al.Nature|December 20, 1984
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityP W Gray, B B Aggarwal, C V Benton, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunityM A Palladino, M R Shalaby, S M Kramer, et al.Neurosurgery|June 13, 2013
Intracranial aneurysms occur more frequently at bifurcation sites that typically experience higher hemodynamic stressesJaclyn M Alfano, John Kolega, Sabareesh K Natarajan, et al.Molecular Carcinogenesis|November 24, 1999
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cellsS K Chintala, A P Kyritsis, P M Mohan, et al.The Journal of Biological Chemistry|February 25, 1985
Human tumor necrosis factor. Production, purification, and characterizationB B Aggarwal, W J Kohr, P E Hass, et al.American Heart Journal|June 22, 2015
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trialKevin R Bainey, Sherali Rahim, Krystal Etherington, et al.European Heart Journal|January 12, 2002
Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary interventionS R Mehta, J W Eikelboom, H-J Rupprecht, et al.Pageof 58